Artelo Biosciences, Inc. Financial Ratios — ARTL Stock

Profitability	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-95.98	-287.99	-81.3	-482.56	-63.15	-85.74	-87.44	-61	-55.51
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.01	- -
Net Debt/EBITDA	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.89	0.67	0.28
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.01	- -
Net Debt/EBIT	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.89	0.67	0.28
EBITDA to Interest Expense	- -	- -	- -	-110.85	- -	- -	- -	- -	-2,057.4	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	-110.85	- -	- -	- -	- -	-2,057.4	- -
EBIT to Interest Expense	- -	- -	- -	-110.85	- -	- -	- -	- -	-2,057.4	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-62.92	-134.3	-1,464.07	-49.41	-664.19	-74.16	-216.2	-133.76	-151.87	-309.03
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.56	0.12	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.4	-0.07	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.53	0.11	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.79	0.32	0.2
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.2	-0.06
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.75	0.31	0.18
Net Debt to Equity	-100	-111.37	26.01	-105.13	249.99	-81.01	-55.28	-55.05	-35.5	-23.95
Net Debt/Capital (%)	61.38	42.68	6.39	66.87	11.34	47.92	18.46	28.29	18.2	6.53
EBITDA	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10
EBITDA-CapEx	- -	- -	- -	- -	-2	-5	-5	-7	-10	-10
Operating Income (Loss)	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10

Liquidity	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	- -	9.79	0.21	19.46	0.63	4.33	4.28	19.13	17.57	8.08
Current Ratio	- -	9.79	0.21	19.51	0.75	4.35	4.66	19.61	18.36	8.51
Quick Ratio	- -	9.79	0.21	19.46	0.68	4.34	4.28	19.13	17.57	8.08
CFO/Avg Current Liab	- -	-15.53	-1.93	-9.26	-5.74	-3.6	-5.71	-11.96	-10.51	-7.17
Common Equity/Total Assets	-62.92	-134.3	-1,464.07	-49.41	-664.19	-74.16	-216.2	-133.76	-151.87	-309.03
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.56	0.12	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.4	-0.07	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.53	0.11	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.79	0.32	0.2
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.2	-0.06
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.75	0.31	0.18
CFO/Total Liabilities	- -	-776.42	-106.32	-736.53	-302.65	-273.39	-867.66	-1,035.58	-784.33	-635.71
CFO/CapEx	- -	- -	- -	- -	-1,905.35	-1.86	- -	- -	- -	- -
Altman's Z-Score	- -	-4.38	-55.38	-0.92	-29.19	-0.49	-7.08	13.78	1.73	-5.12

Working Capital	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	- -	- -	- -	4	4	17	8	4
- Cash & Cash Equivalents	- -	- -	- -	1	- -	4	2	7	7	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	-1	- -	- -	1	7	-9	-6
Total Capital	- -	- -	- -	- -	-3	-5	-9	-17	-31	-40
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.2	-0.06
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.01	-0.01	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	4	4	17	8	4
Diluted Enterprise Value	- -	- -	- -	-1	- -	- -	1	10	1	1
EV per Share	- -	- -	- -	- -	- -	- -	5.73	5.66	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10
TTM Operating Income	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10
TTM Cash Flow to Firm	- -	- -	- -	- -	-2	-3	-4	-6	-8	-8
TTM Free Cash Flow to Firm	- -	- -	- -	- -	-2	-1	-4	-6	-8	-8

Multiples	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	-3.29	-1.33	-2.76	-1.35	-0.64
Price/Earnings High	- -	- -	- -	- -	- -	-5	-3.52	-9.22	-3.11	-1.12
Price/Earnings Low	- -	- -	- -	- -	- -	-1.76	-0.49	-1.13	-0.67	-0.37
Price/Book Value	- -	- -	- -	- -	- -	-0.88	-0.38	-1.01	-0.26	-0.1
Price/Book Value Average	- -	- -	- -	- -	- -	-1.49	-0.65	-1.22	-0.44	-0.15
Price/Book Value High	- -	- -	- -	- -	- -	-2.26	-1.73	-4.06	-1.01	-0.26
Price/Book Value Low	- -	- -	- -	- -	- -	-0.8	-0.24	-0.5	-0.22	-0.08
Price/Tangible Book Value	- -	- -	- -	- -	- -	1.24	1.94	1.7	0.47	0.43
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	2.09	3.36	2.05	0.78	0.61
Price/Tangible Book Value High	- -	- -	- -	- -	- -	3.17	8.93	6.85	1.81	1.07
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	1.12	1.23	0.84	0.39	0.35
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	-1.52	-0.82	-2.77	-1.02	-0.5
Price/Cash Flow Average	- -	- -	- -	- -	- -	-2.56	-1.42	-3.35	-1.7	-0.73
Price/Cash Flow High	- -	- -	- -	- -	- -	-3.89	-3.77	-11.16	-3.92	-1.26
Price/Cash Flow Low	- -	- -	- -	- -	- -	-1.37	-0.52	-1.37	-0.84	-0.41
Price/Free Cash Flow	- -	- -	- -	- -	- -	-3.28	-0.82	-2.77	-1.02	-0.5
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	-5.54	-1.42	-3.35	-1.7	-0.73
Price/Free Cash Flow High	- -	- -	- -	- -	- -	-8.41	-3.77	-11.16	-3.92	-1.26
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	-2.96	-0.52	-1.37	-0.84	-0.41
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.96	1.12	0.12	2.46	0.14	-0.85	-0.86	-1.88	-0.66	-0.32
EV/EBITDA High	0.96	1.12	0.12	2.46	0.14	-2.01	-3.04	-8.33	-2.39	-0.76
EV/EBITDA Low	0.96	1.12	0.12	2.46	0.14	0.19	-0.03	-0.25	0.01	-0.06
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	0.96	1.12	0.12	2.46	0.14	-0.85	-0.86	-1.88	-0.66	-0.32
EV/EBIT High	0.96	1.12	0.12	2.46	0.14	-2.01	-3.04	-8.33	-2.39	-0.76
EV/EBIT Low	0.96	1.12	0.12	2.46	0.14	0.19	-0.03	-0.25	0.01	-0.06
Last Price	- -	- -	- -	- -	- -	29.25	14.4	13.67	2.89	1.4
High Price	- -	- -	- -	- -	- -	75	66.35	55.05	11.07	3.5
Low Price	- -	- -	- -	- -	- -	26.4	9.15	6.77	2.38	1.15
Enterprise Value	- -	- -	- -	-1	- -	- -	1	7	-9	-6
Enterprise Value Average	- -	- -	- -	-1	- -	3	4	14	7	3
Enterprise Value High	- -	- -	- -	-1	- -	6	14	62	25	8
Enterprise Value Low	- -	- -	- -	-1	- -	-1	- -	2	- -	1

Per Share Data Items	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	2	3	3
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	3	3
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	1	3	3
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.6	-0.24	-0.47	-3.2	-27.51	-22.16	-18.96	-5.98	-3.63	-3.35
Operating Income per Share	-0.6	-0.24	-0.47	-3.2	-27.52	-22.16	-18.96	-5.98	-3.63	-3.35
Basic EPS, GAAP	-0.6	-0.24	-0.47	-3.23	-27.52	-15	-18.83	-5.97	-3.56	-3.14
Basic EPS from Cont Ops	-0.6	-0.24	-0.47	-3.23	-27.52	-15	-18.83	-5.97	-3.56	-3.14
Diluted EPS, GAAP	-0.6	-0.24	-0.47	-3.23	-27.52	-15	-18.83	-5.97	-3.56	-3.14
Diluted EPS from Cont Ops	-0.6	-0.24	-0.47	-3.23	-27.52	-15	-18.83	-5.97	-3.56	-3.14
Dividend per Share	- -	- -

Artelo Biosciences, Inc.

Profitability

Credit

Liquidity

Working Capital

Enterprise Value

Multiples

Per Share Data Items